Name | 4-(2-chloro-6-morpholin-4-ylpyrimidin-4-yl)morpholine |
---|---|
Synonyms | 4,6-dimorpholino-2-chloropyrimidine |
Molecular Formula | C12H17ClN4O2 |
---|---|
Molecular Weight | 284.74200 |
Exact Mass | 284.10400 |
PSA | 50.72000 |
LogP | 0.93320 |
~6%
Detail
|
Literature: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Patent: WO2008/98058 A1, 2008 ; Location in patent: Page/Page column 57-58 ; WO 2008/098058 A1 |
~7% 479493-68-0 |
Literature: Burger, Matthew T.; Pecchi, Sabina; Wagman, Allan; Ni, Zhi-Jie; Knapp, Mark; Hendrickson, Thomas; Atallah, Gordana; Pfister, Keith; Zhang, Yanchen; Bartulis, Sarah; Frazier, Kelly; Ng, Simon; Smith, Aaron; Verhagen, Joelle; Haznedar, Joshua; Huh, Kay; Iwanowicz, Ed; Xin, Xiaohua; Menezes, Daniel; Merritt, Hanne; Lee, Isabelle; Wiesmann, Marion; Kaufman, Susan; Crawford, Kenneth; Chin, Michael; Bussiere, Dirksen; Shoemaker, Kevin; Zaror, Isabel; Maira, Sauveur-Michel; Voliva, Charles F. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 10 p. 774 - 779 |
~% 479493-68-0 |
Literature: NOVARTIS AG Patent: WO2007/84786 A1, 2007 ; Location in patent: Page/Page column 123 ; WO 2007/084786 A1 |